TELO
NASDAQ · Pharmaceuticals
Telomir Pharmaceuticals Inc
$1.29
+0.01 (+0.78%)
Open$1.29
Previous Close$1.28
Day High$1.31
Day Low$1.27
52W High$3.10
52W Low$1.05
Volume—
Avg Volume204.5K
Market Cap97.66M
P/E Ratio—
EPS$-0.29
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.55M | 10.11M | 8.56M |
| Net Income | 1.76M | 2.03M | 1.53M |
| Profit Margin | 18.4% | 20.1% | 17.9% |
| EBITDA | 2.43M | 2.63M | 2.21M |
| Free Cash Flow | 1.02M | 1.59M | 1.30M |
| Rev Growth | -2.0% | +7.8% | +19.7% |
| Debt/Equity | 0.60 | 0.70 | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |